Literature DB >> 2196087

Cell-free synthesis of mycolic acids in Mycobacterium aurum: radioactivity distribution in newly synthesized acids and presence of cell wall in the system.

C Lacave1, A Quémard, G Lanéelle.   

Abstract

Distribution of radiolabelling in different parts of the newly synthesized mycolic acids, by a cell-free system from Mycobacterium aurum previously described, is examined, [1-14C]acetate being the precursor. By oxidation cleavage of mycolic acids and examination of the fragments, it was shown that acetate was not uniformly incorporated into the molecule: the methyl terminal part was not labelled, while the central fragments--between unsaturations or between oxygenated functions (oxo or ester) and unsaturations--presented the major part of radioactivity, suggesting the elongation of a preformed compound that the cell-free extract was unable to synthesize. Moreover, the side-chain R2-CH2-COOH was only weakly labelled compared to the central fragments. Since non-hydroxylated fatty acids were not synthesized by the system, it is suggested that de novo C18 fatty acids may be elongated with C2 units by the cell-free extract into C22 fatty derivative, only a low level of labelling being recorded (two C2 units for all the molecule). A scheme is proposed to summarize the main results. Identification of meso-DAP which is a characteristic amino-acid of the peptidoglycan in Actinomycetes and analysis of the profiles of total fatty esters, demonstrated that the cell-free extract is partly constituted by fragments of the cell wall as has already been noticed by examination of micrographs of the extract.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196087     DOI: 10.1016/0005-2760(90)90203-a

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates.

Authors:  J Liu; H Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.

Authors:  P R Wheeler; P M Anderson
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

3.  Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug.

Authors:  G Silve; P Valero-Guillen; A Quemard; M A Dupont; M Daffe; G Laneelle
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

4.  Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.

Authors:  A Quémard; C Lacave; G Lanéelle
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

5.  Reevaluation of envelope profiles and cytoplasmic ultrastructure of mycobacteria processed by conventional embedding and freeze-substitution protocols.

Authors:  T R Paul; T J Beveridge
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

6.  Biosynthetic origin of mycobacterial cell wall arabinosyl residues.

Authors:  M Scherman; A Weston; K Duncan; A Whittington; R Upton; L Deng; R Comber; J D Friedrich; M McNeil
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

7.  S-adenosyl-N-decyl-aminoethyl, a potent bisubstrate inhibitor of mycobacterium tuberculosis mycolic acid methyltransferases.

Authors:  Julien Vaubourgeix; Fabienne Bardou; Fanny Boissier; Sylviane Julien; Patricia Constant; Olivier Ploux; Mamadou Daffé; Annaïk Quémard; Lionel Mourey
Journal:  J Biol Chem       Date:  2009-05-13       Impact factor: 5.157

8.  Mycolic acid synthesis: a target for ethionamide in mycobacteria?

Authors:  A Quémard; G Lanéelle; C Lacave
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.